Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Abundance of severe gum disease like periodontitis may worsen disability for people with multiple sclerosis (MS), a chronic ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

A high burden of severe gum disease, known as periodontitis, may be linked to worsening disability in people living with ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

Abundance of severe gum disease -- periodontitis -- may worsen disability for people with multiple sclerosis (MS), a chronic ...

High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

Chronic respiratory disorders are one of the primary causes of death in patients with multiple sclerosis (MS), but they remain incompletely understood in this population. 1 Identifying diaphragm ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.